©2019 Gilead Sciences, Inc. All rights reserved. UNBP4517 07/19
Cure, or sustained virologic response (SVR12), is defined as undetectable levels of HCV in the blood at 12 weeks after completion of therapy.3,5
If your patient falls within the baby boomer age cohort (born 1945–1965) or a risk factor is identified3:
Select “reflex testing” at the screening step
so a confirmatory HCV RNA test will be run automatically if the antibody test is positive.
aFor persons who might have been exposed to HCV within the past 6 months, consider re-testing for HCV antibodies or ordering an HCV RNA test. For persons who are immunocompromised, testing for HCV RNA can be considered.
bRepeat HCV RNA testing if the person tested is suspected to have had HCV exposure within the past 6 months or has clinical evidence of HCV disease.3
In a cohort of ~9,000 adults who tested positive for HCV antibodies from 2006-2008, 38% did not receive follow-up HCV RNA testing.7 Confirm diagnosis with an HCV RNA test3 and if confirmed initiate treatment or refer the patient to a specialist.
These discussion guides cover each step of the screening and diagnosing process to facilitate productive patient conversations.Download Guides